Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
-
Zhejiang Da Xue Xue Bao Yi Xue Ban · May 2020
Randomized Controlled Trial[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
To evaluate the efficacy and safety of hydroxychloroquine (HCQ) in the treatment of patients with moderate coronavirus disease 2019 (COVID-19). ⋯ The prognosis of COVID-19 moderate patients is good. Larger sample size study are needed to investigate the effects of HCQ in the treatment of COVID-19. Subsequent research should determine better endpoint and fully consider the feasibility of experiments such as sample size.